Protokoly_diagnostiki_i_lechenia_zabolevany

@?@ ( & 1-3)				/					"
	'			&				B &
- %" >55									;
- % # > 65								" .
				(106	–	177	) :
	H &			&/ )				B
	#			H &				!
	> 6,5			"			;
	&/						)			"
	!			"					" &.
					%		) "
	!			,			@ "
	"
				,			" "
							" &
	"-						(			>	177
					"		&/ ).
				%			! :
2. @		,		"			$#
$#		*					%
! % &
							"
J '							"
							.
&							' %
J +							"
6 &
(30-300 / )
							3 ;
+
								& .
$

%

! " %

&

! &- 3 "

"

* « » ( )

" :

" :

- ? , % " " &$ II<, III .

! II< - ) " " –								" " ,
"			& ,		"	"			, ,
$	&,		&.		+	% "
"		: , , " "
		.		' %						% "
" .
! III - &			& "$ , ,
, . !							$		$
$ " . +				% "						( &

&/ ) " : , , " " . ' % % " " . + % & !+.

% " D

' "- % ? D

	"$ ? , %
	& ( " "
	D)
	6 % ?

5 :

1.B ?@

2.7

3.# .

4.# "

5.&

6._ $

:

1.% " ? & ( ?@ 140/90 . . . & "$# $ $ $ &" )

2.$" " &

3.? ( ?@,, % -).

4.' , # $ " " ? : , $# ,, % , & & .

5. ! " " : , ,
&, % %

6." & % " :

# " " , # % , IV , " & ; 7- ( , !-J Sv1+Rv5 35 40 , 45 % 40 ; & Ravl+Sv3 28 %" , 20 % # ), 7G- – ; % 1.2 , ; % 1,2 ; "JD ( 134 /2 %" , 110 /2 % # ); "JD, & & .

7. 7G- " " – " "% " , % & 40%. ".

" & :

1.% ;

2.& , & , , & ;

3." ;

4.L!!;

5.& ;

6.?@;

7.7 ;

8., ;

9.# ;

10." ($, , , , , , );

11.;

12.# " ;

13.;

14.7 ;

15.H)B " .

" & & :

1.;

2.! <;

3.	& & % ;
4.	.

+ :

1.@ , & % ( G!+ 1 _

3 ,	G!+ 2-3 _ 1.2-1,8 / , % G!+ – 4 _ 1 / )
"	% , 750 .

2._" ( & ). +

& . " : 30-60 L!!, $# 75% & . & , 3$& & 7.

3." & .

4.6 .

! % ?@

: V – ?.

@		& B?_, & &
& ,	" & %			& , $#	&
	% & ( " +800 ).
. + "				50-100 / . 6 &	200
/ .		%		" &. ' %
(3-5 ).
_. @ & % " . '

" % " " 3 & . & " & 40-80

/ , %$# 20-40 / .				"
"			/ / , " & 20-50 .
B?_			"$.
	" – (B?_, II,
& ).
B?_ – 3 ( ". 2.5 10 2 / ),					( ".
2 1 / , & 4 / ),				( ". 2.5	20
1 / ). & & G!+ 3 ,
" . + " B?_ & G!+ (
$		– " " "

)

&

"$

.?

< II. 7

-

B?_?

" ? " "

300-600 / ?@.

? & –

%$# 25-50

/ . % " G!+ 150/300 /

,

,

'.

6 &

–

-

( )?.

$

&

& B?_. + "$ $ 1/8 " (

12,5 ). @

$ ( 2 " # " " 2 )

% & " ( 200 / ).

"

( "

)

G!+ &$

% &

, & (" G!+)

$

.?

+ "$

(

0,25

/ )

&

.

" &

% &$ .

" & & :

! ( ).

' & – 3 &, " .

" ( ) $ " G!+?.

+ "$ & $# , & &, "

$		.!
+ – $# :								0,3-0,6 , .			.,	$
	. $ &, % , , "										, 1-2
. ( .) 2 / . ( "							&), & " 4 / ,
12 . &. 6 %				& 3 & ,
1-2 (0,4-0,8 )			. + / 5-200 / (
" !?@, % & & 90 . . .). @											$
" % " 3										" ( &,
). + ?@.
B - &. % , , " . &
& :									% & 3-4
&	1-30		;			20 2-3 ,
							40		60	2 ,
120 1 . ?3 & &
% 1-3 (1.25-3.75 )						/ . J

20-40 1-3 . '/' 2-10 /" ( " !?@, % & & 90 . . .).

< & ( ) "$ & B?_" . + " & 5 1 , %$# 10 / .

? " ( ) $ % % " . ' & : " 1- 200 3 , " 2-200 2 , & %$# 100-400 . '/ : 5-7 / 20-120 . 7 ?@, % 1.2-1,8 / . ( $" &

% % & % " % " !, & ?, % "% "?. ' 3 "

" " & G!+?).

? 75-160 1 .

" & :

1.* 25 ,

2.*_ 40 ,

3.*7 2,5 , 10 ,

4.* 4 ,

5.*J 2,5 , 5 , 10 , 20

6.*! 25 , 50 ,

7.*@ 62,5 , 250 ,

8.6 3 7,5 ., 15 . .

" & & :

1.7 300 ,

2.*? 100 , 500

3.! 5-80 , 4.*J 10 , 20 , 40 ,

,- ! ( !$$ ):

c ?@

" "

& " "

/ , & :

1.Essential hypertension. Guedelines for clinical care. University of Michigan Health system.

2002.

2.« & . ! " " &», 6 , 2003.

3.VHA/DOD Clinical practice guideline for diagnosis and management of hypertension in the primary care setting. 1999.

4.Prodigy guidance. Hypertension. 2003.

5.Management of hypertension in adults in primary care. National institute for clinical excellence. 2004

6.Guidelined and protocols. Detection and diagnosis of hypertension. British Columbia medical association. 2003

7.Michigan quality improvement consortium. Medical management of adults with essential hypertension. 2003

8.? & . ! & V $" $ & % &, .2003.

9. >	#		&	> #
2003.				" $ & .
J.hypertension 2003;21:1011-53

10." $ " " . B.+.@ , M.J.K " .6.2004.

11.The 2003 Canadian Recommendations for the management of hypertension diagnosis.

12.The Seventh Report of the Joint national Committee on prevention, Detection, Evaluation and treatment of high blood pressure. 2003.

13.?.+. @ , 7.

14.D.@., M.'. ? & 2000: $"

. @ , . " .

15. _ & & $ (). ' 6. 6 , 2005.

- , # %-%

' $ !

: 06-073

"$ &: " :

& ! :

1."

2.%

' & &: 8

(:

K52 @ 3

K52.2 ? " 3

K52.1 ; " 3

K52.0 3

) : < ! – &-" . 3 " $, " , % – " .

" " ( ?. .) , ?.'._& , 1985 .)

1." # "

2.' & " "

2.1.G " " 3

2.2.7 & 3

2.3.3

2.4.! 3 3

2.5.; "

2.6.H &

2.7.G " "

2.8.< &

2.9.(3 )

3.) " 3

4."

5._& "

6.@

7.! "

8. @

9."

10.? "

11.? &

12."

$ : " " 3 (5)

I.3 :

1.B ( )

3.; "

4.6

5.?

6.' "

II. -" :

1.G " $ G " G " & 3

2." : >$ >$ & "

>$ % & " >$ & "

III." "$

J " , % , % " _

IV.	&
! " # ( )

! " " ( ) ! 3 3

! & " (3 & " &)

V."

1.< $#

2.! $# ( " & % ," )

VI.	3 &
# ! (!		$	& ! ) – " ,
$# &		# 3

" & % , 3 , " % 3 & ; % , # ; "" , % # .

* : , " , " , : ( , , .), , , .

? " , , " .

" :

" : 3 , % : , & , , % "

5 :

1.#

2.# "

3._

4.? ,

6.$ &

7._ $

8.& 3 , ( )

:

" 3 : " , & % , , , % , % # $ # , &, , ,% , – , .

: ? : 3 30-80%, – &, K- J .

+	:	& : &
3		.
+ :			.
@		# &$	"
:

1.?

2."

3.% -

4.#

5.7-

6.# " IgE #

8.7 $

9." "

10.@ & ( 3 & ,, "" ).

11.? ( , 3 )

@ & # " &$# :

1.! & &

# ( & , , # , , , . .).

2.% & "

3. B " #

4.+ "

5.	% & 3
6.	' # " IgE #
@	3 " % "-

" & " ." 3 % & & .

– 3 " 10-14 " 6-12" .

" & :

1.# (6 )

2.B $ &

3.B $

4.7

6."

7.#

" & & :

3.$

4.?J;

5.-

6.%

7.%

8.?!;

+ :

? " 3 :

1.% ( " # 3-5 " ). 1-2 , ($" $# $ # )

2.? : * 4 4 – 10-15 , &*.

3.+1-: J * 10 / / * 10 / .

" – * 60-120 / .

4.? (+2- : * 300 / _* 40-80 / ; B : * 20-40 /*30-60 / ) – 10-15 .

5.! ( ): * 50-100 3@ * 40 / 2-3- 10-15 .

6.( % $): 6 * @ * 30-40 / 10-15 .

7.– * 2 /$

; " :

1. % , " & ( ). @ " % .

2.? : ! * 4 4 – 10-15 , &. *

3.? (+2- : * 300 / _* 40-80 / ; B : * 20-40 /* 30-60 / .

4.! ( ): *50-100 3< *10 3 @ * 40 / 2-3- 10-15 .

5. ( $): 6 * @ * 30-40 / 10-15 .

6.B (B " - *, 5-10% - @ *) 1-2 / .

7.: *60 . 3 .

8.@ : 3 & * 10 / , 10 ," 1-2 (6).

:

1.@ " % .

2) ? : ! *4 4 – 10-15 , &.* 3) ? (+2- : * 300 /

_* 40-80 / ; B : * 20-40 /* 30-60 / .

4) G- 50 3 .

5); * 200-300 / " 1-2 .

6)! ( ): * 50-100 3< *10 3 @ * 2,0 / 2-3- 10-15 .

7)	( $): 6 *
@ * 30-40 / 10-15 .
8)	B (B " - *, 5-10% - @ *) 1-2